BioArctic & Novartis Announce BrainTransporter‑Enabled Neurodegeneration Collaboration – Up to $772 M Potential Pay‑Out
Swedish biopharma BioArctic AB (publ) (STO: BIOA-B) has entered into an option, collaboration, and license...
STO: BIOA-B
Eisai and BioArctic Set December Launch for Alzheimer’s Drug Leqembi in Japan
Eisai (TYO: 4523) and BioArctic (STO: BIOA-B) have announced the launch of Leqembi (lecanemab) in...
Japan’s MHLW Approves Eisai and BioArctic’s Leqembi for Alzheimer’s Treatment
The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted approval to Eisai...